Keller SM - Search Results

1

Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.

Legrier ME, Yang CP, Yan HG, Lopez-Barcons L, Keller SM, Pérez-Soler R, Horwitz SB, McDaid HM. Legrier ME, et al. Among authors: keller sm. Cancer Res. 2007 Dec 1;67(23):11300-8. doi: 10.1158/0008-5472.CAN-07-0702. Cancer Res. 2007. PMID: 18056456

2

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.

Keller SM, Vangel MG, Adak S, Wagner H, Schiller JH, Herskovic A, Komaki R, Perry MC, Marks RS, Livingston RB, Johnson DH. Keller SM, et al. Lung Cancer. 2002 Sep;37(3):303-9. doi: 10.1016/s0169-5002(02)00103-4. Lung Cancer. 2002. PMID: 12234700 Clinical Trial.

3

Neoadjuvant and adjuvant therapy of non-small cell lung cancer.

Rajdev L, Keller SM. Rajdev L, et al. Among authors: keller sm. Surg Oncol. 2002 Dec;11(4):243-53. doi: 10.1016/s0960-7404(02)00048-8. Surg Oncol. 2002. PMID: 12450560 Review.

4

Adjuvant therapy for locally advanced non-small cell lung cancer.

Keller SM. Keller SM. Lung Cancer. 2003 Dec;42 Suppl 2:S29-34. doi: 10.1016/j.lungcan.2003.08.008. Lung Cancer. 2003. PMID: 14644533 Review. No abstract available.

5

Indirect measurements of differential gene expression with cDNA microarrays.

Belbin TJ, Gaspar J, Haigentz M, Perez-Soler R, Keller SM, Prystowsky MB, Childs G, Socci ND. Belbin TJ, et al. Among authors: keller sm. Biotechniques. 2004 Feb;36(2):310-4. doi: 10.2144/04362MT02. Biotechniques. 2004. PMID: 14989096 Free article.

6

Intraoperative staging and surgical management of stage IIIA/N2 non-small cell lung cancer.

Brichkov I, Keller SM. Brichkov I, et al. Among authors: keller sm. Thorac Surg Clin. 2008 Nov;18(4):381-91. doi: 10.1016/j.thorsurg.2008.08.003. Thorac Surg Clin. 2008. PMID: 19086607 Review.

7

Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.

Ohri N, Piperdi B, Garg MK, Bodner WR, Gucalp R, Perez-Soler R, Keller SM, Guha C. Ohri N, et al. Among authors: keller sm. Lung Cancer. 2015 Jan;87(1):23-7. doi: 10.1016/j.lungcan.2014.10.016. Epub 2014 Nov 6. Lung Cancer. 2015. PMID: 25468149

8

¹⁸F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.

Ohri N, Bodner WR, Halmos B, Cheng H, Perez-Soler R, Keller SM, Kalnicki S, Garg M. Ohri N, et al. Among authors: keller sm. Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):372-380. doi: 10.1016/j.ijrobp.2016.10.031. Epub 2016 Oct 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 28068244

9

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adjei AA, Leighl NB, Aisner SC, Rothman JM, Patel JD, Sborov MD, McDermott SR, Perez-Soler R, Traynor AM, Butts C, Evans T, Shafqat A, Chapman AE, Kasbari SS, Horn L, Ramalingam SS, Schiller JH; ECOG-ACRIN. Wakelee HA, et al. Among authors: keller sm. Lancet Oncol. 2017 Dec;18(12):1610-1623. doi: 10.1016/S1470-2045(17)30691-5. Epub 2017 Nov 9. Lancet Oncol. 2017. PMID: 29129443 Free PMC article. Clinical Trial.

10

Blood transfusion and lung cancer recurrence.

Keller SM, Groshen S, Martini N, Kaiser LR. Keller SM, et al. Cancer. 1988 Aug 1;62(3):606-10. doi: 10.1002/1097-0142(19880801)62:3<606::aid-cncr2820620327>3.0.co;2-q. Cancer. 1988. PMID: 3390797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters